Since FTO promotes melanoma tumorigenicity and regulates the expression of tumor-promoting melanoma cell-intrinsic PD-1 as well as CXCR4 and SOX10, we reasoned that FTO may also regulate the response of melanoma to immunotherapy. Here, CXCR4 is linked to neoplasm.